Canada markets closed

Eton Pharmaceuticals, Inc. (ETON)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.4300-0.0050 (-0.15%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close3.4350
Open3.7000
Bid3.3800 x 100
Ask3.5100 x 100
Day's Range3.3000 - 3.7000
52 Week Range2.4200 - 5.8100
Volume139,532
Avg. Volume62,145
Market Cap88.11M
Beta (5Y Monthly)1.19
PE Ratio (TTM)N/A
EPS (TTM)-0.0400
Earnings DateMay 09, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.00
  • Thomson Reuters StreetEvents

    Q1 2024 Eton Pharmaceuticals Inc Earnings Call

    Q1 2024 Eton Pharmaceuticals Inc Earnings Call

  • GlobeNewswire

    Eton Pharmaceuticals Reports First Quarter 2024 Financial Results

    • Q1 2024 revenue of $8.0 million, representing 50% growth over Q1 2023 and the 13th straight quarter of sequential product sales growth• Acquired PKU GOLIKE®, launched Nitisinone, and submitted a new drug application (NDA) for product candidate ET-400• Management to hold conference call today at 4:30pm ET DEER PARK, Ill., May 09, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commerciali

  • Simply Wall St.

    Eton Pharmaceuticals, Inc. (NASDAQ:ETON) On The Verge Of Breaking Even

    We feel now is a pretty good time to analyse Eton Pharmaceuticals, Inc.'s ( NASDAQ:ETON ) business as it appears the...